You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

~ Buy the POTASSIUM METABISULFITE Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

Drugs Containing Excipient (Inactive Ingredient) POTASSIUM METABISULFITE

✉ Email this page to a colleague

« Back to Dashboard

Branded drugs containing POTASSIUM METABISULFITE excipient, and estimated key patent expiration / generic entry dates

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Meda Pharmaceuticals Inc	ROWASA	mesalamine	0037-0066	POTASSIUM METABISULFITE
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Generic drugs containing POTASSIUM METABISULFITE excipient

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Meda Pharmaceuticals Inc	mesalamine	0037-0066	POTASSIUM METABISULFITE
Septodont Inc	lidocaine hydrochloride and epinephrine	0362-0262	POTASSIUM METABISULFITE
Septodont Inc	lidocaine hydrochloride and epinephrine	0362-0898	POTASSIUM METABISULFITE
Septodont Inc	mepivacaine hydrochloride and levonordefrin	0362-0931	POTASSIUM METABISULFITE
>Company	>Ingredient	>NDC	>Excipient

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.